Just as a trend in the booming marijuana sector – in this case the accelerated pace of negotiations – has become easy to predict, a new turning point has emerged. And it is big, up to 3.4 billion US dollars. Industry observers, as well as investors, will closely monitor this alliance for a variety of reasons.
Earlier this month, Canadian cannabis producer Canopy Growth (NYSE:), (TO:) signed an agreement to acquire US marijuana growers Acreage Holdings (OTC:). This is the first agreement of its kind between two cannabis producers on either side of the border. It could also be the basis of a cannabis superpower in North America.
Since the beginning of 2019, Canopy's shares have exploded, gaining close to 73%, becoming the largest marketable cannabis title. The stock closed at $ 49.10 on Friday.
The current agreement could push the value of the stock much higher … at some point. But for the moment, it is very prudent to consider this agreement as a commitment without a specific date for the marriage. The champagne corks will only be opened when the US federal government has legalized marijuana, as this is the date that this marriage can actually be consumed.
This is necessary because, under Canadian regulations, companies listed on the Toronto Stock Exchange can not own assets in places where marijuana is not legal. And in the United States, these are federal laws, although some state laws have already legalized cannabis.
It is interesting to note, however, that observers are only talking about "when" rather than "if" the US government will officially recognize the state's stateful move towards the legalization of marijuana.
Under the terms of the agreement, Canopy Growth will make an initial payment of $ 300 million as soon as Acreage Holding shareholders approve the transaction. Then, when Canopy Growth takes control, Acreage shareholders will receive just over half the value of a Canopy share – or 0.5818 shares of stock to be exact – for every Acreage share that they hold.
Bruce Linton, President and CEO of Canopy Growth, summarized the importance of this agreement:
"Our right to acquire Acreage guarantees our entry strategy into the United States as soon as a federally authorized route exists."
Introducing this path to the world's largest marijuana market is a huge step forward for Canopy. Other cannabis companies wishing to locate in the United States have so far sought to partner only with companies in states that have legalized the product. Canopy will be able to leverage its expanding business not only for marijuana growing, but also for the research and development of pharmaceutical cannabis, oils and food products.
"When the right is exercised, access to Canopy Growth's deep resources will enable us to innovate, develop and distribute quality cannabis brands in the United States and continue to expand our US footprint," said Linton. . "At the same time, a convergence of factors much more often prevents a multi-state operator from realizing its full potential, including the huge amount of cash needed to evolve."
With the Acreage agreement, Canopy will be present in 20 states, a market valued at more than 17 billion US dollars.
The other leading Canadian connection in Acreage
Canopy Growth's acquisition of US company Acreage Holding is not the only Canadian connection for the US company. Brian Mulroney, former Prime Minister of Canada, is a member of its board of directors. Many have interpreted Mulroney's position on the Acreage board, which also includes former US House Speaker John Boehner, as a sign that legalization in the United States is a bankable event.
For investors, however, this latest transaction, while large, is not the largest of Canopy Growth. Last November, she signed a $ 4 billion deal with Constellation Brands (NYSE:), the US-based beer and wine producer, and the home of iconic brands like Corona and Robert Mondavi. This agreement gave Constellation a 37% interest in the company based in Smith Fall, Ontario.
And the contracts continue to accumulate. In March alone, Canopy announced three strategic agreements: the acquisition of US hemp producer AgriNextUSA, a multi-year agreement with HollWeed North Cannabis, based in British Columbia, and an extension of its partnership with OG DNA Genetics.
The AgriNextUSA agreement was signed in the wake of the adoption of the US Farm Bill, which legalized hemp. The agreement provides for Canopy to invest between US $ 100 million and US $ 150 million in AgriNextUSA's hemp production business in New York.
Canopy's multi-year agreement with HollyWeed North Cannabis provides for the processing of dried cannabis at a plant in Victoria, British Columbia, for use in the production of high quality oil and resin. This will help Canopy better meet the demand for new CBD-infused food products, which are expected to arrive in Canadian markets later this year, when they become legal.
During the month of March, Canopy also announced the extension of its partnership with OG DNA Genetics, a cannabis brand recognized worldwide, to introduce the company's reputable genetic technology into the European market. The details of the expansion plan have not been disclosed, but the partnership is now in effect until 2024.
Here’s what you need to know before seeing your local medical dispensary:You will need a doctor’s recommendation, medical cannabis certification, and/or whatever appropriate documentation is needed by your condition. Typically, you need to be 18 or older to be eligible for a medical consent, but exceptions may be made in some states for minors with particularly debilitating problems. You will usually enroll with a medicinal dispensary. This is to maintain your medical cannabis recommendation or certificate on file for legal and regulatory purposes. There’ll be a waiting space. This will be to control the circulation of patients and product, but a straightforward dividing wall also gives patients solitude and direct one-on-one contact with a budtender to candidly discuss medical problems. This procedure can assist budtenders and patients monitor effective medicine as well as possess a living record of producers and goods for future reference and follow-up. Medicinal dispensaries usually permit you to smell and analyze the buds prior to buy. This may differ from state-to-state.
DOES AN APPLICANT NEED MUNICIPAL APPROVAL BEFORE RECEIVING A RETAIL CANNABIS LICENSE? Yes, municipal approval is required before the AGLC will issue a retail cannabis license. Applicants should get in touch with their planned municipality to learn requirements regarding municipal retail cannabis legislation, zoning requirements, land-use limitations, and place requirements regarding how near a retail store can be into a provincial medical care centre, school, or parcel of property designated as a school reserve.
Keep non-medical cannabis legal Adults who are 19 decades or older are in a position to:Have up to 30 gram of legal dried cannabis or the equivalent in their own person. Share up to 30 gram of legal cannabis along with other adults in Canada. Purchase cannabis products from a Yukon Liquor Corporation licensed merchant. Grow up to four crops per household. It’s illegal to provide non invasive cannabis to anyone under the age of 19 and also for anybody below the age of 19 to possess any quantity of non-medical cannabis in Yukon.It is illegal and dangerous to drive while under the influence of cannabis or other intoxicants.